Wave Life Sciences Ltd. (WVE)
Nasdaq: WVE · Pharmaceutical Preparations · Singapore, SG · filing with the SEC since 2015
Who runs Wave Life Sciences Ltd.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Bolno Paul
President and CEO. First filing Nov 2015, latest Feb 11, 2026, 20 filings in all.
Officers reporting now
6
of 17 people with a filing in the last fifteen months
Directors reporting now
11
26 people on the record since 2015
Officerssales are open-market, Oct 7, 2025 to Oct 7, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Ingelsson Erik | Chief Scientific Officer | Apr 2026 | Apr 17, 2026 | none |
| Wright Christopher I | Chief Medical Officer | Apr 2026 | Apr 17, 2026 | none |
| Francis Chris | SVP, Corporate Development, Head of Emerging Areas | Nov 2015 | Feb 27, 2026 | 14 · $7.1M |
| Bolno Paul | President and CEO | Nov 2015 | Feb 11, 2026 | 1 · $100,000 |
| Moran Kyle | Chief Financial Officer | Nov 2015 | Feb 11, 2026 | 7 · $4.2M |
| Vargeese Chandra | Chief Technology Officer, Head of Platform Discovery Sciences | Nov 2015 | Feb 11, 2026 | 1 · $0.00 |
Directorssales are open-market, Oct 7, 2025 to Oct 7, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Corrigan Mark | director | Sep 2019 | Oct 7, 2026 | 2 · $200,000 |
| Henry Christian O | director | Nov 2016 | Oct 7, 2026 | 4 · $1.4M |
| Kolchinsky Peter | director | Nov 2015 | Oct 7, 2026 | none |
| Ra Capital Healthcare Fund LP | director | Nov 2015 | Oct 7, 2026 | none |
| Ra Capital Management, LLC | director | Nov 2015 | Oct 7, 2026 | none |
| Rawcliffe Adrian | director | Feb 2017 | Oct 7, 2026 | 3 · $800,000 |
| Shah Rajeev M. | director | Apr 2021 | Oct 7, 2026 | none |
| Takanashi Ken | director | Nov 2015 | Oct 7, 2026 | 1 · $0.00 |
| Tan Aik Na | director | Aug 2020 | Oct 7, 2026 | 9 · $1.8M |
| Verdine Gregory L. | director | Nov 2015 | Oct 7, 2026 | 2 · $300,000 |
| Wagner Heidi L | director | Sep 2019 | Oct 7, 2026 | 3 · $200,000 |
Owners of more than 10% of a classsales are open-market, Oct 7, 2025 to Oct 7, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Gsk PLC | 10% owner | Jan 2023 | Dec 15, 2025 | none |
Earlier names on the record10, newest filing first
Panzara Michael A. · officer · last filing Jul 2022Pott Amy · director · last filing Aug 2020Gaiero David G · officer · last filing Mar 2020Miura Koji · director · last filing Aug 2019Baldry Mark · officer · last filing Aug 2019Regnante Keith · officer · last filing Mar 2019Tanaka Masaharu · director · last filing Sep 2017Kagoshima Shinsangyo Sousei Investment Limited Partnership · 10% owner · last filing Sep 2017Guerciolini Roberto · officer · last filing Dec 2016Wada Takeshi · director · last filing Nov 2016
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.